<DOC>
	<DOC>NCT00710619</DOC>
	<brief_summary>This study is conducted in the United States of America (USA). The aim of this study is to investigate the at-home-administration of bypassing agents for treatment of bleeding episodes in patients with congenital haemophilia with inhibitors to factors VIII and IX. We are further investigating how bleeding episodes affect the quality of life of the patient and their family or caregivers.</brief_summary>
	<brief_title>Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Male subjects with congenital haemophilia A or B and inhibitors with spontaneous bleeds which require ondemand treatment Subjects prescribed NovoSevenÂ® as the first line or recommended bypass agent History of on average at least 4 bleeds of any type over a 3 month period Subject or caregiver able and willing to complete daily journal for 3 months Informed consent obtained from all subjects or legal representative</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>